Healio

FDA approves Epioxa for keratoconus

Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...

Next-gen coil interface for non-contact peripheral nerve stimulation could improve treatment for chronic pain

A research team has successfully developed a next-generation coil interface capable of efficiently and safely stimulating ...
Healio

FDA approves Yuflyma for adolescent hidradenitis suppurativa, pediatric uveitis

The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, ...
Ophthalmology Times

Glaukos receives FDA approval for Epioxa topical therapy for keratoconus

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...
Lupus Foundation of America

FDA Approves Gazyva® (obinutuzumab) for the Treatment of Adults with Lupus Nephritis

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...